acute myocardial infarction

Infarct size reduction to 30 days could result in clinical benefit at one year

Original title:&nbsp;Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: One-year results from the INFUSE-AMI trial.&nbsp;Reference:&nbsp;Stone GW et al. Circ Cardiovasc Interv. 2013;Epub ahead of print. &nbsp; The intra-coronary infusion of Abciximab added to thromboaspiration seems to improve outcomes at one year in patients undergoing primary angioplasty for ST-segment elevation with anterior<a href="https://solaci.org/en/2013/10/16/infarct-size-reduction-to-30-days-could-result-in-clinical-benefit-at-one-year/" title="Read more" >...</a>

Ticagrelor effective in venous bridges

Original title:&nbsp;Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass grafo surgery: Inssights from th PLATelet inhibition and patients outcomes (PLATO) trial.&nbsp;Reference:&nbsp;Emmanouil S. Brilakis, et al. Am Heart J 2013;166:474-80 &nbsp; The bridge venous occlusion is a common finding in patients with previous CABG presenting with acute coronary syndrome without ST<a href="https://solaci.org/en/2013/09/27/ticagrelor-effective-in-venous-bridges/" title="Read more" >...</a>

Transradial Angioplasty: do we need more proof to adopt it for good?

Original title:&nbsp;Influence of Arterial Access Site Selection on Outcomes in Primary Percutaneous Coronary Intervention. Are the Results of Randomized Trials Achievable in Clinical Practice?&nbsp;Reference:&nbsp;Mamas A. Mamas et al. J Am Coll Cardiol Intv 2013. Article in press. Antithrombotic therapy has improved the prognosis of patients with acute ST-segment elevation myocardial infarction by reducing ischemic events.<a href="https://solaci.org/en/2013/06/25/transradial-angioplasty-do-we-need-more-proof-to-adopt-it-for-good/" title="Read more" >...</a>

Direct Stent, no clinical utility in patients undergoing elective

&nbsp;Original title: The Independent Value of a Direct Stenting Strategy on Early and Late Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention. Reference: Gabriel L. Sardi et al. Catheterization and Cardiovascular Interventions 81:949&ndash;956 (2013). &nbsp; The use of direct stenting (DS) without pre-stenting dilation has proven to be a safe strategy, especially with the<a href="https://solaci.org/en/2013/06/18/direct-stent-no-clinical-utility-in-patients-undergoing-elective/" title="Read more" >...</a>

Adenosine, the best vasodilator to improve blood flow in primary angioplasty

Original title:&nbsp;Open Label, Randomized, Placebo-Controlled Evaluation of Intracoronary Adenosine or Nitroprusside Alter Thrombus Aspiration During Primary Percutaneous Coronary Intervention for the Prevention of Microvascular Obstruction in Acute Myocardial Infartion . The Reopen-AMI Study&nbsp;Reference:&nbsp;Giampaolo Niccoli, et al. J Am Coll Cardiol Intv 2013. Article in Press One of the challenges of PCI is to achieve the<a href="https://solaci.org/en/2013/06/13/adenosine-the-best-vasodilator-to-improve-blood-flow-in-primary-angioplasty/" title="Read more" >...</a>

MitraClip® in real life

Original title:&nbsp;Acute outcomes after MitraClip&reg; therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry.&nbsp;Reference:&nbsp;Wolfgang Schillinger et al. EuroIntervention 2013; 8-online publish-ahead-of-print April 2013. Recently, percutaneous repair of the mitral valve with MitraClip&reg;, (Abbott Vascular, Santa Clara, CA, USA), has emerged as an option for patients with severe mitral regurgitation,<a href="https://solaci.org/en/2013/04/17/mitraclip-in-real-life/" title="Read more" >...</a>

5 Year Follow Up Outcome of Zotarolimus Eluting Stent

Original title:&nbsp;The &#8220;Final&#8221; 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent. ENDEAVOR IV Investigators&nbsp;Reference:&nbsp;Ajay J. Kirtane et al. J Am Coll Cardiol Intv 2013. Article in press. The ENDEAVOR IV was a randomized controlled study with a noninferiority design that compared the Endeavor zotarolimus eluting stent (Medtronic, Santa<a href="https://solaci.org/en/2013/04/12/5-year-follow-up-outcome-of-zotarolimus-eluting-stent/" title="Read more" >...</a>

Complete revascularization in one procedure is more cost effective and as safe as in stages.

Original title:&nbsp;Staged Versus One-time Complete Revascularization With Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease Patients Without ST-Elevation Myocardial Infarction.&nbsp;Reference:&nbsp;Edward L. Hannan et al. Circ Cardiovasc Interv 2013;6;12-20. There is evidence that in patients with multi-vessel disease affected by an acute coronary syndrome (ACS) with ST segment elevation, only the cause lesion should be treated<a href="https://solaci.org/en/2013/03/04/complete-revascularization-in-one-procedure-is-more-cost-effective-and-as-safe-as-in-stages/" title="Read more" >...</a>

Ischemic preconditioning reduces infarct size in patients treated with primary angioplasty

Original title:&nbsp;Preinfarction Angina Reduces Infarct Size in ST-Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention&nbsp;Reference:&nbsp;Ronald Reiter et al. Circ Cardiovasc Interv. 2013;6:00-00. Ischemic preconditioning (IPC) is a phenomenon whereby transitory ischemia episodes protect the myocardium against a more prolonged episode.&nbsp; Until now, IPC has been the most effective approach to protect the myocardium. Pre infarction<a href="https://solaci.org/en/2013/02/08/ischemic-preconditioning-reduces-infarct-size-in-patients-treated-with-primary-angioplasty/" title="Read more" >...</a>

Spontaneous coronary artery dissection (SCAD) is associated with fibro-muscular dysplasia in other territories

Original title:&nbsp;Spontaneous Coronary Artery Dissection. Prevalence of Predisposing Conditions Including Fibromuscular Dysplasia in a Tertiary Center Cohort&nbsp;Reference:&nbsp;Jacqueline Saw, et al. J Am Coll Cardiol Intv 2013;6:44 &ndash;52 Non atherosclerotic spontaneous coronary artery dissection (Non atherosclerotic SCAD) is a rare disease that is associated with acute myocardial infarction and sudden death.&nbsp; This condition is more common<a href="https://solaci.org/en/2013/01/24/spontaneous-coronary-artery-dissection-scad-is-associated-with-fibro-muscular-dysplasia-in-other-territories/" title="Read more" >...</a>

Top